April 8 was the last update on clinical trials site to change status to recruiting. Six week stabilisation period. 20th May is 6 weeks.
So from tomorrow could hear of patients dosing, but doubt they would recruit on day 1.
Ann: FDA IND Approval for Phase 3 Study of DMX-200 in FSGS, page-13
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
52.0¢ |
Change
-0.030(5.45%) |
Mkt cap ! $285.8M | |||
| Open | High | Low | Value | Volume |
| 54.5¢ | 55.5¢ | 51.5¢ | $1.982M | 3.739M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 82244 | 52.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 53.0¢ | 27153 | 1 |
View Market Depth
| Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
| DXB (ASX) Chart |